drugset / Trial / NCT02629224
ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the pharmacokinetics and safety of ASP8825 in patients with impaired renal function and haemodialysis.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gabapentin enacarbil | Small molecule | — | Oral |
Indications
No indication recorded.